At a glance
- Originator Fujisawa
- Class Antihypertensives; Small molecules
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 22 May 2001 No-Development-Reported for Hypertension in Japan (Unknown route)
- 23 Jun 1998 Commercial data has been reviewed by Fujisawa
- 19 Nov 1996 New profile